|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2009-10-12
|
|
pubmed:abstractText |
Obesity increases the risk of proteinuria and chronic renal insufficiency and hastens the progression of renal diseases. Increased activity of renin-angiotensin-aldosterone system and elevated levels of aldosterone are common in obese patients. No studies have compared the efficacy of the currently available antiproteinuric strategies (ACE inhibitors -ACEI-, angiotensin receptor blockers -ARB-, aldosterone antagonists) in obese patients with proteinuric renal diseases.
|
|
pubmed:language |
spa
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0211-6995
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
29
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
421-9
|
|
pubmed:meshHeading |
pubmed-meshheading:19820754-Adult,
pubmed-meshheading:19820754-Aged,
pubmed-meshheading:19820754-Aldosterone Antagonists,
pubmed-meshheading:19820754-Angiotensin II Type 1 Receptor Blockers,
pubmed-meshheading:19820754-Angiotensin-Converting Enzyme Inhibitors,
pubmed-meshheading:19820754-Benzimidazoles,
pubmed-meshheading:19820754-Female,
pubmed-meshheading:19820754-Humans,
pubmed-meshheading:19820754-Lisinopril,
pubmed-meshheading:19820754-Male,
pubmed-meshheading:19820754-Middle Aged,
pubmed-meshheading:19820754-Obesity,
pubmed-meshheading:19820754-Prospective Studies,
pubmed-meshheading:19820754-Proteinuria,
pubmed-meshheading:19820754-Spironolactone,
pubmed-meshheading:19820754-Tetrazoles
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
[The antiproteinuric effect of the blockage of the renin-angiotensin-aldosterone system (RAAS) in obese patients. Which treatment option is the most effective? ].
|
|
pubmed:affiliation |
Servicio de Nefrologia, Hospital Universitario 12 de Octubre, Madrid, Spain. emoralesr@senefro.org
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
English Abstract,
Randomized Controlled Trial
|
